Rating History for Monopar Therapeutics (MNPR) by Cantor Fitzgerald

More Stocks Rated by Cantor Fitzgerald | Latest Ratings for MNPR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/13/2026 Kirsten Kluska Downgrade Neutral
(Overweight)		 119.00
(109.00)		 114.46
(109.96)		 -3.93% Details